Literature DB >> 28505368

Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway.

Shogo Takahashi1, Naoki Tanaka1,2, Srujana Golla1, Tatsuki Fukami1, Kristopher W Krausz1, Marianne A Polunas3, Blair C Weig4, Yusuke Masuo1, Cen Xie1, Changtao Jiang1, Frank J Gonzalez1.   

Abstract

Hepatotoxicity is of major concern for humans exposed to industrial chemicals and drugs. Disruption of farnesoid X receptor (FXR), a master regulator of bile acid (BA) metabolism, enhanced the sensitivity to liver injury in mice after toxicant exposure, but the precise mechanism remains unclear. In this study, the interconnection between BA metabolism, FXR, and chemically induced hepatotoxicity was investigated using metabolomics, Fxr-null mice (Fxr-/-) and hepatocytes, and recombinant adenoviruses. A single low-dose intraperitoneal injection of carbon tetrachloride (CCl4), an inducer of acute hepatitis in mice, resulted in more severe hepatocyte damage and higher induction of pro-inflammatory mediators, such as chemokine (C-C motif) ligand 2 (Ccl2), in Fxr-/-. Serum metabolomics analysis revealed marked increases in circulating taurocholate (TCA) and tauro-β-muricholate (T-β-MCA) in these mice, and forced expression of bile salt export protein (BSEP) by recombinant adenovirus in Fxr-/- ameliorated CCl4-induced liver damage. Treatment of Fxr-null hepatocytes with TCA, but not T-β-MCA, significantly increased c-Jun-N-terminal kinase (JNK) activation and Ccl2 mRNA levels, and up-regulation of Ccl2 mRNA was attenuated by co-treatment with a JNK inhibitor SP600125, indicating that TCA directly amplifies hepatocyte inflammatory signaling mainly mediated by JNK under FXR-deficiency. Additionally, pretreatment with SP600125 or restoration of FXR expression in liver by use of recombinant adenovirus, attenuated CCl4-induced liver injury. Collectively, these results suggest that the TCA-JNK axis is likely associated with increased susceptibility to CCl4-induced acute liver injury in Fxr-/-, and provide clues to the mechanism by which FXR and its downstream gene targets, such as BSEP, protects against chemically induced hepatotoxicity. Published by Oxford University Press on behalf of the Society of Toxicology 2017. This work is written by US Government employees and is in the public domain in the United States.

Entities:  

Keywords:  CCl4; bile acids; c-Jun-N-terminal kinase; farnesoid X receptor; taurocholate

Mesh:

Substances:

Year:  2017        PMID: 28505368      PMCID: PMC5837376          DOI: 10.1093/toxsci/kfx094

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  45 in total

1.  Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice.

Authors:  A M Reimold; J Kim; R Finberg; L H Glimcher
Journal:  Int Immunol       Date:  2001-02       Impact factor: 4.823

2.  Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line.

Authors:  Runping Liu; Xiaojiaoyang Li; Xiaoyan Qiang; Lan Luo; Phillip B Hylemon; Zhenzhou Jiang; Luyong Zhang; Huiping Zhou
Journal:  J Biol Chem       Date:  2015-10-30       Impact factor: 5.157

Review 3.  FXR signaling in the enterohepatic system.

Authors:  Tsutomu Matsubara; Fei Li; Frank J Gonzalez
Journal:  Mol Cell Endocrinol       Date:  2012-05-17       Impact factor: 4.102

4.  JNK mediates hepatic ischemia reperfusion injury.

Authors:  Tetsuya Uehara; Brydon Bennett; Steve T Sakata; Yoshitaka Satoh; Graham K Bilter; John K Westwick; David A Brenner
Journal:  J Hepatol       Date:  2005-04-07       Impact factor: 25.083

5.  Metabolic preconditioning protects BSEP/ABCB11-/- mice against cholestatic liver injury.

Authors:  Claudia D Fuchs; Gustav Paumgartner; Annika Wahlström; Philipp Schwabl; Thomas Reiberger; Nadja Leditznig; Tatjana Stojakovic; Nataliya Rohr-Udilova; Peter Chiba; Hanns-Ulrich Marschall; Michael Trauner
Journal:  J Hepatol       Date:  2016-09-01       Impact factor: 25.083

6.  Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

Authors:  Changtao Jiang; Cen Xie; Fei Li; Limin Zhang; Robert G Nichols; Kristopher W Krausz; Jingwei Cai; Yunpeng Qi; Zhong-Ze Fang; Shogo Takahashi; Naoki Tanaka; Dhimant Desai; Shantu G Amin; Istvan Albert; Andrew D Patterson; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

7.  Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice.

Authors:  Elena Zamara; Sara Galastri; Sara Aleffi; Ilaria Petrai; Manuela Aragno; Raffaella Mastrocola; Erica Novo; Cristiana Bertolani; Stefano Milani; Francesco Vizzutti; Alessandro Vercelli; Massimo Pinzani; Giacomo Laffi; Giorgio LaVilla; Maurizio Parola; Fabio Marra
Journal:  J Hepatol       Date:  2006-10-23       Impact factor: 25.083

8.  Hydrophobic bile acid apoptosis is regulated by sphingosine-1-phosphate receptor 2 in rat hepatocytes and human hepatocellular carcinoma cells.

Authors:  Cynthia R L Webster; M Sawkat Anwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-17       Impact factor: 4.052

9.  Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Meihua Wang; Donna Yu; Barry M Forman; Wendong Huang
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

10.  FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach.

Authors:  Weiqiang Lu; Feixiong Cheng; Jing Jiang; Chen Zhang; Xiaokang Deng; Zhongyu Xu; Shien Zou; Xu Shen; Yun Tang; Jin Huang
Journal:  Sci Rep       Date:  2015-01-29       Impact factor: 4.379

View more
  9 in total

1.  Celastrol ameliorates acute liver injury through modulation of PPARα.

Authors:  Qi Zhao; Ping Tang; Ting Zhang; Jian-Feng Huang; Xue-Rong Xiao; Wei-Feng Zhu; Frank J Gonzalez; Fei Li
Journal:  Biochem Pharmacol       Date:  2020-05-26       Impact factor: 5.858

2.  Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.

Authors:  Cen Xie; Shogo Takahashi; Chad N Brocker; Shijun He; Li Chen; Guomin Xie; Katrina Jang; Xiaoxia Gao; Kristopher W Krausz; Aijuan Qu; Moshe Levi; Frank J Gonzalez
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-06-10       Impact factor: 4.698

Review 3.  Farnesoid X receptor: a potential therapeutic target in multiple organs.

Authors:  Chao Zhang; Zixuan Wang; Qingqing Feng; Wei-Dong Chen; Yan-Dong Wang
Journal:  Histol Histopathol       Date:  2021-01-04       Impact factor: 2.303

4.  Bile Acid Toxicity and Protein Kinases.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Gene Expr       Date:  2019-06-28

6.  Pleiotropic roles of FXR in liver and colorectal cancers.

Authors:  Xiongfei Huang; Mingjie Fan; Wendong Huang
Journal:  Mol Cell Endocrinol       Date:  2022-01-04       Impact factor: 4.102

7.  FXR-Deoxycholic Acid-TNF-α Axis Modulates Acetaminophen-Induced Hepatotoxicity.

Authors:  Tingting Yan; Nana Yan; Hong Wang; Tomoki Yagai; Yuhong Luo; Shogo Takahashi; Min Zhao; Kristopher W Krausz; Guangji Wang; Haiping Hao; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2021-05-27       Impact factor: 4.849

Review 8.  The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.

Authors:  Lulu Sun; Jie Cai; Frank J Gonzalez
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-02-10       Impact factor: 46.802

Review 9.  Update on FXR Biology: Promising Therapeutic Target?

Authors:  Chang Yeob Han
Journal:  Int J Mol Sci       Date:  2018-07-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.